Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 12.
doi: 10.1007/s11302-024-10000-7. Online ahead of print.

The functional role of P2 purinergic receptors in the progression of gastric cancer

Fei-Long Zou  1 , Ji-Peng Liu  2 , Cheng Zuo  2 , Peng-Fei He  2 , Jin-Xiong Ye  3 , Wen-Jun Zhang  4
Affiliations
Review

The functional role of P2 purinergic receptors in the progression of gastric cancer

Fei-Long Zou et al. Purinergic Signal. .

Abstract

Studies have confirmed that P2 purinergic receptors (P2X receptors and P2Y receptors) expressed in gastric cancer (GC) cells and GC tissues and correlates with their function. Endogenous nucleotides including ATP, ADP, UTP, and UDP, as P2 purinergic receptors activators, participate in P2 purinergic signal transduction pathway. These activated P2 purinergic receptors regulate the progression of GC mainly by mediating ion channels and intracellular signal cascades. It is worth noting that there is a difference in the expression of P2 purinergic receptors in GC, which may play different roles in the progression of GC as a tumor promoting factor or a tumor suppressor factor. Among them, P2 × 7, P2Y2 and P2Y6 receptors have certain clinical significance in patients with GC and may be used as biological molecular markers for the prediction of patients with GC. Therefore, in this paper, we discuss the functional role of nucleotide / P2 purinergic receptors signal axis in regulating the progression of GC and that these P2 purinergic receptors may be used as potential molecular targets for the prevention and treatment of GC.

Keywords: GC; P2X receptors; P2Y receptors; Treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Zhang WJ, Hu DX, Lin SJ, Fang XQ, Ye ZF (2022) Contribution of P2X purinergic receptor in cerebral ischemia injury. Brain Res Bull 190:42–49 - PubMed - DOI
    1. Zhang WJ (2021) Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy. Purinergic Signal 17(1):151–162 - PubMed - PMC - DOI
    1. Di Virgilio F, Vultaggio-Poma V, Sarti AC (2021) P2X receptors in cancer growth and progression. Biochem Pharmacol 187:114350 - PubMed - DOI
    1. Burnstock G (2014) Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal 10(1):3–50 - PubMed - DOI
    1. Hevia MJ, Castro P, Pinto K, Reyna-Jeldes M, Rodríguez-Tirado F, Robles-Planells C, Ramírez-Rivera S, Madariaga JA, Gutierrez F, López J, Barra M, De la Fuente-Ortega E, Bernal G, Coddou C (2019) Differential effects of Purinergic Signaling in Gastric Cancer-Derived cells through P2Y and P2X receptors. Front Pharmacol 10:612 - PubMed - PMC - DOI

LinkOut - more resources